{"Title": ["Stock Alert: Compugen Jumps 9%", "SCZ, KRNT, CGEN, RDWR: ETF Outflow Alert", "CYCN Awaits Sickle Cell Disease Data, TTPH Finalizes Its Suitor, ADMS Faces FDA In Feb", "Compugen: FDA Allows Phase 1/2 Study Evaluating COM701 With BMS-986207 And Nivolumab", "2 Top Biotech Picks for May", "Compugen Ltd. (CGEN) Q1 2020 Earnings Call Transcript", "Can This Biotech Shed New Light on Cancer Immunotherapies?", "Interesting CGEN Call Options For December 2021", "Stock Alert: Compugen Jumps 9%", "3 Monster Growth Stocks Gearing up for Gains", "RCUS Abuzz, FDA Approves First Therapy For LG UTUC, VNDA Joins COVID-19 Battle", "Here's Why Compugen Jumped Higher Today", "Compugen Ltd. (CGEN) Q4 2019 Earnings Call Transcript", "Compugen (CGEN) Hits A High - A Transformative Year Gone, A Busy Year Ahead", "Compugen Ltd. (CGEN) Q3 2019 Earnings Call Transcript", "Healthcare Stocks That Hit New Highs ( REPH, CNMD, DRNA,...)", "Compugen sees \"encouraging signals\" from early-stage cancer trial", "Compugen Ltd. (CGEN) Q1 2019 Earnings Call Transcript", "Achillion (ACHN) Reports Narrower-Than-Expected Loss in Q4", "Compugen (CGEN) Upgraded to Strong Buy: What Does It Mean for the Stock?", "Merrimack (MACK) Incurs Narrower-Than-Expected Loss in Q4", "Bristol-Myers, Infinity to Test Opdivo Combo for Bladder Cancer", "Compugen (CGEN) Reports Q3 Loss", "What's in the Cards for Perrigo (PRGO) This Earnings Season?", "Compugen Ltd. (CGEN) Q2 2019 Earnings Call Transcript", "What's in the Cards for Nektar (NKTR) This Earnings Season?", "Compugen Ltd. (CGEN) Sees Hammer Chart Pattern: Time to Buy?", "Bristol-Myers Reports Disappointing Data From SCLC Study", "Bristol-Myers Inks Deal and Invests $12 Million in Compugen", "Mid-Day Update: Selling Continues on Wall Street As Interest Rates, Trade, Global Growth Plague Wall Street", "Market Has Not Yet Noticed Potential in Compugen; Have You?", "Health Care Sector Update for 03/29/2018: CGEN,BIOC,PSDV,HRTX", "What Lies in Store for Ligand (LGND) This Earnings Season?", "What's in the Cards for Nektar (NKTR) This Earnings Season?", "Compugen Ltd. (CGEN) Sees Hammer Chart Pattern: Time to Buy?", "Company News For Oct 10, 2017", "Mid-Day Market Update: La-Z-Boy Drops After Q1 Miss; Paratek Pharmaceuticals Shares Rise", "Mid-Morning Market Update: Markets Open Lower; Lowe's Earnings Miss Expectations", "Mid-Morning Market Update: Markets Mostly Lower; Halliburton Profit Tops Estimates", "Health Care Sector Update for 05/31/2017: TNXP,XTNT,CGEN", "Health Care Sector Update for 03/29/2018: LIVN,PSDV,CGEN,BIOC", "Health Care Sector Update for 03/29/2018: CPRX,CGEN,BIOC,PSDV,HRTX", "What Makes Compugen Ltd. (CGEN) a Strong Sell?", "What Falling Estimates & Price Mean for Atara Biotherapeutics (ATRA)", "Zacks.com featured highlights: Amarin, Compugen, Raptor Pharmaceuticals, ArcelorMittal and Hovnanian Enterprises", "Compugen (CGEN) Looks Good: Stock Adds 5.1% in Session", "Explosive Stocks Under $10", "How Compugen (CGEN) Stock Stands Out in a Strong Industry", "Health Care Sector Update for 05/31/2017: CBIO,XTNT,CGEN", "Health Care Sector Update for 06/08/2015: CNCE, CGEN", "Compugen (CGEN) is in Overbought Territory: What's Next? - Tale of the Tape", "New Strong Sell Stocks for May 28th - Tale of the Tape", "Falling Earnings Estimates Signal Weakness Ahead for Compugen (CGEN) - Tale of the Tape", "Zacks Rank #1 Additions for Wednesday - Tale of the Tape", "Zacks Rank #1 Additions for Monday - Tale of the Tape", "Moving Average Crossover Alert: Compugen (CGEN) - Tale of the Tape", "Is a Surprise Coming for Compugen (CGEN) This Earnings Season?", "Compugen (CGEN) Worth Watching: Stock Moves 8.8% Higher - Tale of the Tape", "Investors' Radars Failed to Catch Compugen (CGEN), Has Yours? - Tale of the Tape", "Compugen (CGEN) Worth Watching: Stock Adds 6% in Session - Tale of the Tape", "Compugen (CGEN) Enters Oversold Territory - Tale of the Tape", "Should Compugen (CGEN) Be On Your Radar Now? - Tale of the Tape", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Can The Uptrend Continue for Compugen (CGEN)? - Tale of the Tape", "Will Compugen (CGEN) Continue to Surge Higher? - Tale of the Tape", "Sector Update: Health Care", "Sector Update: Health Care Shares Lower Pre-Market", "Sector Update: Health Care", "Sector Update: Health-Care Shares Mixed Pre-Market; Compugen up 3% on Milestone with Bayer", "Sector Update: Health Care", "Sector Update: Health-Care Shares Rise Pre-Market; NeoStem Granted Two European Patents", "Pre-Market Earnings Report for May 19, 2014 : CPB, VAL, CGEN, RRST", "Zacks Rank #1 Additions for Thursday - Tale of the Tape", "Sector Update: Healthcare", "Pre-Market Most Active for Feb 28, 2014 : VZ, VOD, JCP, DPM, DDD, ARIA, ALU, MDVN, BAC, FB, DECK, CGEN", "Sector Update: Healthcare Shares Flat to Lower Pre-Market; Compugen Dives 16% on Offering Plans", "Sector Update: Healthcare", "Bayer in Oncology Deals - Analyst Blog", "Company News for August 6, 2013 - Corporate Summary", "Bayer Inks Oncology Deal - Analyst Blog", "Sector Update: Healthcare Shares Flat Pre-Market; Compugen Rallies 4% on Buy Rating at Jefferies", "Healthcare Reform and the Bottom Line", "Market Wrap For Monday, August 5: Stocks Close Mixed; Nasdaq Rises, Dow And S&P Fall Modestly"], "Elapsed Time": ["JUN 12, 2020", "JUN 9, 2020", "JUN 4, 2020", "JUN 1, 2020", "MAY 20, 2020", "MAY 6, 2020", "MAY 4, 2020", "APR 30, 2020", "JUN 12, 2020", "APR 24, 2020", "APR 16, 2020", "MAR 10, 2020", "FEB 21, 2020", "FEB 3, 2020", "NOV 11, 2019", "NOV 1, 2019", "APR 27, 2020", "MAY 20, 2019", "MAR 8, 2019", "MAR 7, 2019", "MAR 7, 2019", "NOV 7, 2018", "NOV 7, 2018", "NOV 6, 2018", "AUG 5, 2019", "NOV 5, 2018", "NOV 5, 2018", "OCT 15, 2018", "OCT 12, 2018", "OCT 11, 2018", "MAY 16, 2018", "MAR 29, 2018", "NOV 6, 2018", "NOV 5, 2018", "NOV 5, 2018", "OCT 10, 2017", "AUG 23, 2017", "AUG 23, 2017", "JUL 24, 2017", "MAY 31, 2017", "MAR 29, 2018", "MAR 29, 2018", "DEC 20, 2016", "OCT 27, 2016", "SEP 7, 2016", "SEP 6, 2016", "SEP 6, 2016", "AUG 18, 2016", "MAY 31, 2017", "JUN 8, 2015", "JUN 4, 2015", "MAY 28, 2015", "MAY 13, 2015", "MAR 11, 2015", "MAR 9, 2015", "FEB 27, 2015", "NOV 2, 2015", "DEC 8, 2014", "NOV 24, 2014", "NOV 21, 2014", "NOV 18, 2014", "NOV 5, 2014", "OCT 2, 2014", "SEP 5, 2014", "DEC 10, 2014", "AUG 6, 2014", "AUG 6, 2014", "JUL 7, 2014", "JUL 7, 2014", "MAY 19, 2014", "MAY 19, 2014", "MAY 16, 2014", "AUG 14, 2014", "MAR 19, 2014", "FEB 28, 2014", "FEB 28, 2014", "FEB 28, 2014", "OCT 15, 2013", "AUG 6, 2013", "AUG 6, 2013", "MAR 19, 2014", "MAR 22, 2010", "AUG 5, 2013"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/stock-alert%3A-compugen-jumps-9-2020-06-12", "https://www.nasdaq.com/articles/scz-krnt-cgen-rdwr%3A-etf-outflow-alert-2020-06-09", "https://www.nasdaq.com/articles/cycn-awaits-sickle-cell-disease-data-ttph-finalizes-its-suitor-adms-faces-fda-in-feb-2020", "https://www.nasdaq.com/articles/compugen%3A-fda-allows-phase-1-2-study-evaluating-com701-with-bms-986207-and-nivolumab-2020", "https://www.nasdaq.com/articles/2-top-biotech-picks-for-may-2020-05-20", "https://www.nasdaq.com/articles/compugen-ltd.-cgen-q1-2020-earnings-call-transcript-2020-05-07", "https://www.nasdaq.com/articles/can-this-biotech-shed-new-light-on-cancer-immunotherapies-2020-05-04", "https://www.nasdaq.com/articles/interesting-cgen-call-options-for-december-2021-2020-04-30", "https://www.nasdaq.com/articles/stock-alert%3A-compugen-jumps-9-2020-06-12", "https://www.nasdaq.com/articles/3-monster-growth-stocks-gearing-up-for-gains-2020-04-24", "https://www.nasdaq.com/articles/rcus-abuzz-fda-approves-first-therapy-for-lg-utuc-vnda-joins-covid-19-battle-2020-04-16", "https://www.nasdaq.com/articles/heres-why-compugen-jumped-higher-today-2020-03-10", "https://www.nasdaq.com/articles/compugen-ltd.-cgen-q4-2019-earnings-call-transcript-2020-02-21", "https://www.nasdaq.com/articles/compugen-cgen-hits-a-high-a-transformative-year-gone-a-busy-year-ahead-2020-02-03", "https://www.nasdaq.com/articles/compugen-ltd.-cgen-q3-2019-earnings-call-transcript-2019-11-11", "https://www.nasdaq.com/articles/healthcare-stocks-that-hit-new-highs-reph-cnmd-drna...-2019-11-01", "https://www.nasdaq.com/articles/compugen-sees-encouraging-signals-from-early-stage-cancer-trial-2020-04-27", "https://www.nasdaq.com/articles/compugen-ltd.-cgen-q1-2019-earnings-call-transcript-2019-05-20", "https://www.nasdaq.com/articles/achillion-achn-reports-narrower-than-expected-loss-in-q4-2019-03-08", "https://www.nasdaq.com/articles/compugen-cgen-upgraded-to-strong-buy%3A-what-does-it-mean-for-the-stock-2019-03-07", "https://www.nasdaq.com/articles/merrimack-mack-incurs-narrower-than-expected-loss-in-q4-2019-03-07", "https://www.nasdaq.com/articles/bristol-myers-infinity-to-test-opdivo-combo-for-bladder-cancer-2018-11-07", "https://www.nasdaq.com/articles/compugen-cgen-reports-q3-loss-2018-11-07", "https://www.nasdaq.com/articles/whats-in-the-cards-for-perrigo-prgo-this-earnings-season-2018-11-06", "https://www.nasdaq.com/articles/compugen-ltd.-cgen-q2-2019-earnings-call-transcript-2019-08-05", "https://www.nasdaq.com/articles/whats-in-the-cards-for-nektar-nktr-this-earnings-season-2018-11-05", "https://www.nasdaq.com/articles/compugen-ltd.-cgen-sees-hammer-chart-pattern%3A-time-to-buy-2018-11-05", "https://www.nasdaq.com/articles/bristol-myers-reports-disappointing-data-from-sclc-study-2018-10-15", "https://www.nasdaq.com/articles/bristol-myers-inks-deal-and-invests-%2412-million-in-compugen-2018-10-12", "https://www.nasdaq.com/articles/mid-day-update-selling-continues-wall-street-interest-rates-trade-global-growth-plague", "https://www.nasdaq.com/articles/market-has-not-yet-noticed-potential-in-compugen-have-you-2018-05-16", "https://www.nasdaq.com/articles/health-care-sector-update-03292018-cgenbiocpsdvhrtx-2018-03-29", "https://www.nasdaq.com/articles/what-lies-in-store-for-ligand-lgnd-this-earnings-season-2018-11-06", "https://www.nasdaq.com/articles/whats-in-the-cards-for-nektar-nktr-this-earnings-season-2018-11-05", "https://www.nasdaq.com/articles/compugen-ltd.-cgen-sees-hammer-chart-pattern%3A-time-to-buy-2018-11-05", "https://www.nasdaq.com/articles/company-news-for-oct-10-2017-2017-10-10", "https://www.nasdaq.com/articles/mid-day-market-update-la-z-boy-drops-after-q1-miss-paratek-pharmaceuticals-shares-rise", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-lowes-earnings-miss-expectations-2017-08-23", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-lower-halliburton-profit-tops-estimates-2017-07", "https://www.nasdaq.com/articles/health-care-sector-update-05312017-tnxpxtntcgen-2017-05-31", "https://www.nasdaq.com/articles/health-care-sector-update-03292018-livnpsdvcgenbioc-2018-03-29", "https://www.nasdaq.com/articles/health-care-sector-update-03292018-cprxcgenbiocpsdvhrtx-2018-03-29", "https://www.nasdaq.com/articles/what-makes-compugen-ltd.-cgen-a-strong-sell-2016-12-20", "https://www.nasdaq.com/articles/what-falling-estimates-price-mean-for-atara-biotherapeutics-atra-2016-10-27", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-amarin-compugen-raptor-pharmaceuticals-arcelormittal-and", "https://www.nasdaq.com/articles/compugen-cgen-looks-good%3A-stock-adds-5.1-in-session-2016-09-06", "https://www.nasdaq.com/articles/explosive-stocks-under-10-2016-09-06", "https://www.nasdaq.com/articles/how-compugen-cgen-stock-stands-out-in-a-strong-industry-2016-08-18", "https://www.nasdaq.com/articles/health-care-sector-update-05312017-cbioxtntcgen-2017-05-31", "https://www.nasdaq.com/articles/health-care-sector-update-06082015-cnce-cgen-2015-06-08", "https://www.nasdaq.com/articles/compugen-cgen-is-in-overbought-territory%3A-whats-next-tale-of-the-tape-2015-06-04", "https://www.nasdaq.com/articles/new-strong-sell-stocks-for-may-28th-tale-of-the-tape-2015-05-28", "https://www.nasdaq.com/articles/falling-earnings-estimates-signal-weakness-ahead-for-compugen-cgen-tale-of-the-tape-2015", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-wednesday-tale-of-the-tape-2015-03-11", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-monday-tale-of-the-tape-2015-03-09", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-compugen-cgen-tale-of-the-tape-2015-02-27", "https://www.nasdaq.com/articles/is-a-surprise-coming-for-compugen-cgen-this-earnings-season-2015-11-02", "https://www.nasdaq.com/articles/compugen-cgen-worth-watching%3A-stock-moves-8.8-higher-tale-of-the-tape-2014-12-08", "https://www.nasdaq.com/articles/investors-radars-failed-to-catch-compugen-cgen-has-yours-tale-of-the-tape-2014-11-24", "https://www.nasdaq.com/articles/compugen-cgen-worth-watching%3A-stock-adds-6-in-session-tale-of-the-tape-2014-11-21", "https://www.nasdaq.com/articles/compugen-cgen-enters-oversold-territory-tale-of-the-tape-2014-11-18", "https://www.nasdaq.com/articles/should-compugen-cgen-be-on-your-radar-now-tale-of-the-tape-2014-11-05", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-10-02", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-compugen-cgen-tale-of-the-tape-2014-09-05", "https://www.nasdaq.com/articles/will-compugen-cgen-continue-to-surge-higher-tale-of-the-tape-2014-12-10", "https://www.nasdaq.com/articles/sector-update-health-care-2014-08-06-1", "https://www.nasdaq.com/articles/sector-update-health-care-shares-lower-pre-market-2014-08-06", "https://www.nasdaq.com/articles/sector-update-health-care-2014-07-07", "https://www.nasdaq.com/articles/sector-update-health-care-shares-mixed-pre-market-compugen-3-milestone-bayer-2014-07-07", "https://www.nasdaq.com/articles/sector-update-health-care-2014-05-19", "https://www.nasdaq.com/articles/sector-update-health-care-shares-rise-pre-market-neostem-granted-two-european-patents-2014", "https://www.nasdaq.com/articles/pre-market-earnings-report-may-19-2014-cpb-val-cgen-rrst-2014-05-16", "https://www.nasdaq.com/articles/zacks-rank-1-additions-for-thursday-tale-of-the-tape-2014-08-14", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-03-19-1", "https://www.nasdaq.com/articles/pre-market-most-active-feb-28-2014-vz-vod-jcp-dpm-ddd-aria-alu-mdvn-bac-fb-deck-cgen-2014", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-lower-pre-market-compugen-dives-16-offering-plans", "https://www.nasdaq.com/articles/sector-update-healthcare-2014-02-28-1", "https://www.nasdaq.com/articles/bayer-in-oncology-deals-analyst-blog-2013-10-15", "https://www.nasdaq.com/articles/company-news-for-august-6-2013-corporate-summary-2013-08-06", "https://www.nasdaq.com/articles/bayer-inks-oncology-deal-analyst-blog-2013-08-06", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-compugen-rallies-4-buy-rating-jefferies", "https://www.nasdaq.com/articles/healthcare-reform-and-bottom-line-2010-03-22", "https://www.nasdaq.com/articles/market-wrap-monday-august-5-stocks-close-mixed-nasdaq-rises-dow-and-sp-fall-modestly-2013"], "Content": []}